SELLAS Life Sciences Group Files for $200M Mixed Shelf Offering
Thursday, 28 March 2024, 20:54
SELLAS Life Sciences Group Files for $200M Mixed Shelf Offering
SELLAS Life Sciences Group has filed a prospectus for a $200 million mixed securities shelf offering.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.